Abstract:AIM:To explore the changes in extracellular regulated protein kinase (ERK1/2) in the hypertrophic myocardium induced by pressure overload at the different time courses and to determine the molecular mechanism in the myocardium from hypertrophy to heart failure. METHODS:C57/BL mice,aged 12 week old,were subjected to sham-operation (SH) or transversing aortic constriction (TAC) to establish left ventricular hypertrophy. Echocardiographic assessments,hemodynamic determination,organ weight measurement,morphological and histological examination were performed at 1,4,8,12 and 16 weeks after surgery. Meanwhile mRNA levels of atrial natriuretic peptide (ANP),α-myosin heavy chain (α-MHC),bcl-2 and bax were measured by RT-PCR,and ERK1/2 levels were detected by Western blotting. The animals in SH group were performed the same tests then sacrificed at 16 weeks. RESULTS:(1) Compared to SH group,LVESd,LVEDd,Awsth,Awdth,Pwsth and Pwdth progressively increased after TAC. Meanwhile,ejection fraction (EF%) significantly decreased at 16th week (P<0.05). LVSP,dp/dtmax and dp/dtmin in TAC group were progressively increased after 4 weeks. From 8-12 weeks these parameters maintained stable and then sharply decreased at 16th week (all P<0.05). However,LVEDP was statistically increased at 8th week. These echocardiographic and hemodynamic changes indicated a development of LVH and eventually progressing towards to heart failure. (2) Histologically,cardiac collagen measured by percentage of Sirius red positive stained area and apoptosis index showed progressive increases from 4 to 16 weeks. (3) Compared to SH group,mRNA levels of ANP was time-dependently increased while α-MHC and Bcl-2 were time-dependently decreased. The ratio of Bcl-2 /Bax was decreased. Phosphorylation of ERK1/2 was increased at 4th week,then decreased with age of TAC (all P<0.05). CONCLUSION:Pressure-overload induced by TAC results in a development of LVH from early concentric hypertrophy to late eccentric hypertrophy,and eventually toward cardiac dysfunction or heart failure. Those changes are associated with increase in cell size and cardiac fibrosis. ERK1/2 signaling pathway may involve in the regulation of myocardial cell apoptosis in hypertrophic and failure heart.

ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation

Role of extracellular signal-regulated kinase 1/2 signaling underlying cardiac hypertrophy

Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation.

Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy

Roles of ERKs and Intracellular Free Calcium in Cardiomyocyte Hypertrophic Response Induced by Endothelin-1

Differential ERK1/2 Signaling and Hypertrophic Response to Endothelin-1 in Cardiomyocytes from SHR and Wistar-Kyoto Rats: A Potential Target for Combination Therapy of Hypertension

Cooperative Binding of ETS2 and NFAT Link Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

Activation of ERK5 in angiotensin II-induced hypertrophy of human aortic smooth muscle cells

ERK1/2 signaling pathway mediates PDGF-CC-induced rat cardiac fibrosis and its mechanism

The Ubiquitin Ligase HERC2 Promotes Ang II-induced Cardiac Hypertrophy Via Destabilization of MeCP2 to Enhance Lin28a Expression

Hypertrophic response to angiotensin II is mediated by protein kinase D-extracellular signal-regulated kinase 5 pathway in human aortic smooth muscle cells.

ERK1/2: An Integrator of Signals That Alters Cardiac Homeostasis and Growth

The expression of α-enolase in hypertrophic cardiomyocytes induced by endothelin-1(ET-1)and regulation mechanism for the expression

Effects of ERK1/2 on pressure overload-induced cardiomyopathy and heart failure in mice

Transactivated EGFR Mediates Α₁-Ar-induced STAT3 Activation and Cardiac Hypertrophy.

Mitogen-activated protein kinases ERK 1/2-and p38-GATA-4 pathways mediate the Ang II-induced activation of FGF-2 gene in neonatal rat cardiomyocytes

Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism

Cardiac Ankyrin Repeat Protein Attenuates Cardiac Hypertrophy by Inhibition of ERK1/2 and TGF-β Signaling Pathways.

Role of ERK1/2 and PI3-K in the Regulation of CTGF-induced ILK Expression in HK-2 Cells

Abstract P234: CTMP Negatively Regulates Pathological Cardiac Hypertrophy via Akt-dependent Manner